adequate hematologic function as: defined by an absolute neutrophil count > 1500/ml, hematocrit > 24 %, and platelet count > 100,000/ml. Patients with hematocrit between 24 % and 30 % should undergo transfusion or treatment with epoetin, and may be enrolled. [clinicaltrials_resource:5747911e2e34533de04ffd28948c6dd3]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
adequate hematologic function as: defined by an absolute neutrophil count > 1500/ml, hematocrit > 24 %, and platelet count > 100,000/ml. Patients with hematocrit between 24 % and 30 % should undergo transfusion or treatment with epoetin, and may be enrolled. [clinicaltrials_resource:5747911e2e34533de04ffd28948c6dd3]
Bio2RDF identifier
5747911e2e34533de04ffd28948c6dd3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5747911e2e34533de04ffd28948c6dd3
identifier
clinicaltrials_resource:5747911e2e34533de04ffd28948c6dd3
title
adequate hematologic function ...... epoetin, and may be enrolled.
@en
type
label
adequate hematologic function ...... 7911e2e34533de04ffd28948c6dd3]
@en